Hound Partners’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
MCMC
SIG
BBA
TM
TCM
FAM
Hound Partners's ADPT Position: Q3 2019 in Review
Hound Partners sold out of Adaptive Biotechnologies (ADPT) in Q3 2019, closing a stake of 50,000 shares — an estimated $2.42M sold.
Hound Partners first reported a position in ADPT in Q2 2019 and held it in 1 quarter. The position peaked at $2.42M in Q2 2019. 117 funds tracked by Wall St. Rank hold ADPT as of Q3 2019.
- Hound Partners reported no remaining Adaptive Biotechnologies position as of Q3 2019 after selling out during the quarter.
- Hound Partners sold 50,000 Adaptive Biotechnologies shares in Q3 2019, an estimated $2.42M.
- Hound Partners first reported a position in Adaptive Biotechnologies in Q2 2019 and held it in 1 quarter.
- Hound Partners's Adaptive Biotechnologies position peaked at $2.42M in Q2 2019.
- 117 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2019.
Based on Hound Partners's 13F filing for Q3 2019, filed 14 Nov 2019.